CervoMed (CRVO) Net Income (2010 - 2026)
CervoMed (CRVO) posted Net Income of -$8.1 million for Q1 2026, little changed sequentially from -$8.1 million in Q4 2025, and down 52.04% YoY from -$16.9 million in Q1 2025.
CervoMed (CRVO) Net Income (2010 - 2026) Analysis & Trends
CervoMed has reported Net Income for 17 years, with the latest figure at -$8.1 million in Q1 2026.
- Quarterly Net Income fell 52.04% year-over-year to -$8.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$30.6 million (down 49.61% YoY) and the FY2025 annual result came in at -$27.0 million, down 48.34% from the prior year.
- Net Income steadied at -$8.1 million in Q1 2026 per CRVO's latest filing, from -$8.1 million in the prior quarter.
- Over five years, Net Income peaked at -$1.2 million in Q2 2023 and troughed at -$8.1 million in Q1 2026.
- A 5-year average of -$4.6 million and a median of -$4.4 million in 2022 frame the typical range for Net Income.
- The sharpest annual moves came in 2022 and 2024: Net Income soared 77.06% in 2022, then sank 179.1% in 2024.
- Over 5 years, Net Income stood at -$4.1 million in 2022, then jumped by 35.74% to -$2.6 million in 2023, then tumbled by 179.1% to -$7.3 million in 2024, then retreated by 10.67% to -$8.1 million in 2025, then fell by 0.33% to -$8.1 million in 2026.
- According to Business Quant data, Net Income over the past three periods registered -$8.1 million, -$8.1 million, and -$7.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 482.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -782.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 237.01 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 164.49 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -355.03 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -13.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 81.49 Mn |
| 10 | CervoMed | 26.64 Mn | 26.64 Mn | - | -6.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6.57 Mn |
| Mar 31, 2026 | -8.12 Mn |
| Dec 31, 2025 | -8.09 Mn |
| Sep 30, 2025 | -7.73 Mn |
| Jun 30, 2025 | -6.64 Mn |
| Mar 31, 2025 | -5.34 Mn |
| Dec 31, 2024 | -7.31 Mn |
| Sep 30, 2024 | -4.75 Mn |
| Jun 30, 2024 | -3.04 Mn |
| Mar 31, 2024 | -2.59 Mn |
| Dec 31, 2023 | -2.62 Mn |
| Sep 30, 2023 | -2.63 Mn |
| Jun 30, 2023 | -1.25 Mn |
| Mar 31, 2023 | -1.39 Mn |
| Dec 31, 2022 | -4.08 Mn |
| Sep 30, 2022 | -2.80 Mn |
| Jun 30, 2022 | -4.37 Mn |
| Mar 31, 2022 | -4.65 Mn |
| Dec 31, 2021 | -3.07 Mn |
| Sep 30, 2021 | -12.20 Mn |